WELCOME TO INTRATUS
We bring innovative, elegant, easy to administer, sustained-release
transdermal drug delivery technology to patients.
Intratus, Inc. is a privately held, clinical-stage life sciences company dedicated to the development of its patented, novel, non-invasive, sustained release, and elegant drug delivery platform technologies.
The Intratus portfolio is focused on the treatment of a multitude of ophthalmic diseases in all segments of the eye. Additionally, the platform technology extends to systemic diseases such as cardiovascular disease, diabetes and allergy & immunology.
The company’s IP portfolio provides the foundation for monetizing its internally discovered R&D assets. Intratus is presently headquartered in San Diego, California with operational capacity in the U.S.A., Europe, Asia and South America.
5330 Carroll Canyon Road,
San Diego, CA 92121, USA